Abstract
Background: To uncover advanced prognosis biomarkers in patients with kidney renal clear cell carcinoma (KIRC), our study was the first to make a comprehensive analysis of hsa-mir-21 predicted target genes and explore the immune characteristics in KIRC. Methods: The comprehensive analysis of hsa-mir-21 predicted target genes and immune characteristics in KIRC were analyzed via TIMER2.0, UALCAN, Metascape, Kaplan-Meier plotter, Human Protein Atlas, CancerSEA, JASPAR, GEPIA, and R packages (GSVA, RMS, SURVIVAL). Results: Up-transcriptional expressions of RP2, NFIA, and SPRY1 were significantly associated with favorable prognosis in KIRC, whereas TGFBI was markedly associated with unfavorable prognosis. Additionally, these genes were significantly relevant to immune infiltration. ZNF263 was identified as a common predicted transcription factor and an independent prognostic indicator. Conclusions: Hsa-mir-21 predicted target genes (RP2, NFIA, SPRY1, and TGFBI) and the common transcription factor ZNF263 could serve as advanced prognosis biomarkers in KIRC patients.
Introduction
Kidney Renal Clear Cell Carcinoma (KIRC) represents the most prevalent and aggressive subtype of kidney cancer. Despite advancements in surgical and systemic therapies, approximately one-third of patients eventually face metastatic progression, which significantly diminishes survival rates. The molecular heterogeneity of KIRC complicates prognosis; while markers like VHL or BAP1 offer some guidance, there is a critical need for more precise biomarkers that reflect both tumor biology and the immune landscape. This study investigates hsa-mir-21, a microRNA frequently overexpressed in malignancies, and its downstream target genes to identify novel prognostic signatures.
Methods
The researchers utilized a robust bioinformatic pipeline to analyze large-scale genomic data from repositories such as TCGA and the Human Protein Atlas. The workflow included:
- Target Prediction: Integration of TargetScan, microRNA.org, and miRDB to identify potential hsa-mir-21 targets.
- Expression Analysis: UALCAN was used to compare gene expression in KIRC versus normal tissues across various demographic factors.
- Survival Correlation: Kaplan-Meier plotter and GEPIA assessed the impact of gene expression on Overall Survival (OS) and Disease-Free Survival (DFS).
- Immune Profiling: TIMER2.0 and the ssGSEA algorithm correlated gene expression with immune cell infiltration (e.g., T cells, macrophages).
- Regulatory Mapping: JASPAR predicted common transcription factors driving the expression of these target genes.
Results
hsa-mir-21 as a Key Driver
Initial analysis confirmed that hsa-mir-21 is significantly overexpressed in KIRC tumor tissues compared to normal controls. This differential expression is consistent across various clinical subgroups and is a hallmark of the disease's transcriptomic profile.
Crucially, high levels of hsa-mir-21 correlate strongly with poor patient outcomes. Survival analysis demonstrated that patients with elevated hsa-mir-21 expression have significantly lower survival probabilities ($P < 0.0001$), establishing it as a potent unfavorable prognostic factor.
Identification of Prognostic Target Genes
While microRNAs typically downregulate targets, this study identified 14 target genes that were paradoxically up-regulated alongside hsa-mir-21 in KIRC. Among these, four genes emerged as significant prognostic indicators:
- Favorable Markers: High expression of RP2 (HR=0.49), NFIA (HR=0.49), and SPRY1 (HR=0.54) was associated with a nearly 50% reduction in the risk of death.
- Unfavorable Marker: High expression of TGFBI (HR=1.9) nearly doubled the risk of death and peaked in Stage 4 disease.
Immune Infiltration and Transcription Regulation
The expression of these four genes significantly correlated with immune cell infiltration. Notably, TGFBI was linked to increased macrophage presence, which often contributes to an immunosuppressive tumor microenvironment. Furthermore, the study identified ZNF263 as a common transcription factor for all four genes. ZNF263 itself was found to be a favorable prognostic indicator, suggesting it acts as a central regulatory node in a protective gene network.
Discussion and Limitations
This study provides a comprehensive look at the hsa-mir-21 regulatory axis in KIRC, identifying a four-gene signature and a master transcription factor (ZNF263) with high prognostic value. However, as a purely bioinformatic study, these findings require experimental validation. Future research should focus on in vitro and in vivo models to elucidate the exact mechanisms by which NFIA and SPRY1 exert their protective effects and to confirm the clinical utility of this signature in prospective trials.
Summary updated